Leukocyte and microparticles fractionation using microfluidics

METHODS OF RATIONALLY DESIGNING A PERSONALIZED NUTRITIONAL PLAN

DIAGNOSTIC TARGET

Immune cell trapping devices and methods for making and using the same

METHOD, APPARATUS AND ELECTROCHEMICAL TEST DEVICE

METHODS AND DEVICES FOR DETERMINING METABOLIC STATES

SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS

METHOD OF DETECTION OF OCCULT PANCREATIC BETA CELL DYSFUNCTION IN NORMOGLYCEMIC PATIENTS

METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT

COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES

Insulin mimotopes and methods of using the same

SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT

PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS

DIABETES TREATMENT

METHOD OF DIGITIZING NUTRITIONAL STATUS, MUSCLE TURNOVER, AND RISK ASSESSMENT

Use of human small leucine zipper protein in adipocyte differentiation procedure

METHOD FOR MEASURING URINARY APOE CONCENTRATION

Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent

Detection of oligosaccharides

Compositions and Methods for Identifying and Modulating Metabolic Health

IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES

NOVEL MARKER FOR GESTATIONAL DIABETES

Methods for determining the level of hyposialylation of Angptl4

Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

Methods for predicting glucoregulatory dysfunction via diacylglycerol fatty acid species concentrations

Biomarkers

Dermatopontin as a therapeutic for metabolic disorders

Aptamers and sensing technology used for detection of glycated hemoglobin in whole blood

DEVICES FOR DETECTION OF ANTIBODIES AGAINST THERAPEUTIC DRUGS

Diagnostic methods, therapeutic agents and uses thereof

Systems and methods for detection of chemtiluminescent reactions

PROTEIN AND LIPID BIOMARKERS PROVIDING CONSISTENT IMPROVEMENT TO THE PREDICTION OF TYPE 2 DIABETES

THERMOELECTRIC SENSOR FOR ANALYTES IN A GAS AND RELATED METHOD

Method for the early diagnosis of a pre-diabetic state and type 2 diabetes

Methods of diagnosing and predicting renal disease

Metabolite Biomarkers Predictive Of Renal Disease In Diabetic Patients

DEVICES FOR DETECTION OF AN ANALYTE IN URINE AND METHODS OF USING SAME

Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy

Nanoparticle probes and methods of making and use thereof

Disease prevention and alleviation by human myoblast transplantation

Animal model for non alcoholic steato hepatitis and liver fibrosis

Methods and compositions for reducing blood glucose levels

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Determination of glycosaminoglycan levels by mass spectrometry

Glucagon/GLP-1 receptor co-agonists

NEW C-GLYCOSYLPOLYPHENOL ANTIDIABETIC AGENTS, EFFECT ON GLUCOSE TOLERANCE AND INTERACTION WITH BETA-AMYLOID. THERAPEUTIC APPLICATIONS OF THE SYNTHESIZED AGENT(S) AND OF GENISTA TENERA ETHYL ACETATE EXTRACTS CONTAINING SOME OF THOSE AGENTS

Methods and compositions to treat type-1 and type-2 diabetes

Approach to treatment of hyperglycemia using a nanoparticle encapsulated peptide

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

METHODS FOR DETECTING GESTATIONAL DIABETES MELLITUS

METHOD OF EXTRACTING ORGAN METABOLIC FUNCTIONS USING ORAL GLUCOSE TOLERANCE TESTS AND DEVICE THEREFOR

Methods and compositions for diagnosis and management of diabetes and metabolic syndrome

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Method for identifying an agent for treating abnormal kidney function

Methods, systems, and computer readable media for physiology parameter-invariant meal detection

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

QUINOLINES AND THEIR USE FOR TREATING ENDOPLASMIC RETICULUM STRESS-CAUSED DISEASES

IDENTIFICATION OF MODULATORS OF BINDING PROPERTIES OF ANTIBODIES REACTIVE WITH A MEMBER OF THE INSULIN RECEPTOR FAMILY

Methods for monitoring physiological status of a body organ

Gas sensor element

Methods of treating autoimmunity

Nanoparticle probes and methods of making and use thereof

Anthracenyl-tetralactam macrocycles and their use in detecting a target saccharide

Compositions and methods for diagnosis and treatment of metabolic syndrome

Rapid screening and evaluation of diabetes and prediabetes by glycated hemoglobin mass spectrometry

Method for detecting and purifying pancreatic beta cells

Systems and methods for obtaining information associated with an anatomical sample using optical microscopy

Method for evaluating or selecting agent for suppressing GIP level elevation

Methods for treatment using anti-NMU agents

BIOCHEMICAL MARKERS FOR USE IN DETERMINING RISK OF DIABETES

Methods for producing hormone secreting cells in a subject

Surrogates of post-translationally modified proteins and uses thereof

Compositions and methods for regulating glucose metabolism

In vitro process for the quantification of carboxymethyl and carboxyethyl level of albumin in a sample

Means and methods for determining risk of type-1 diabetes by serum protein biomarkers

Early prediction markers of diabetic nephropathy

A METHOD OF SCREENING FOR A COMPOUND CAPABLE OF STIMULATING GLUCOSE TRANSPORT INTO BROWN AND/OR BRITE ADIPOCYTES OF A MAMMAL, A KIT FOR USE IN SUCH A METHOD

Flattop (FLTP) is a novel biomarker for beta cell maturation

ApoIII and the treatment and diagnosis of diabetes

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

Methods and reagents for the assessment of gestational diabetes

FGF21 protein with enhanced binding affinity for β-Klotho for the treatment of type II diabetes, obesity, and related metabolic disorders

A NOVEL SOLUBLE BIOMARKER FOR INSULIN RESISTANCE

Method for identifying and quantifying carboxyethyl valine modified haemoglobin

Compositions and methods for regulating pancreatic beta cell function using adipsin

Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes

METHOD AND MEANS FOR THE NON-INVASIVE DIAGNOSIS OF TYPE II DIABETES MELLITUS

Method for treating or preventing a pancreatic dysfunction

Chimeric fibroblast growth factor 21 proteins and methods of use

SURROGATES OF POST-TRANSLATIONALLY MODIFIED PROTEINS AND USES THEREOF

Screening method, a kit, a method of treatment and a compound for use in a method of treatment

Protein and lipid biomarkers providing consistent improvement to the prediction of Type 2 diabetes

Methods and systems for diagnosing diseases

Porous semiconductor metal oxide complex nanofibers including nanoparticle catalyst functionalized by nano-catalyst included within metal-organic framework, gas sensor and member using the same, and method of manufacturing the same

Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof

System and method for cell levitation and monitoring

METHOD OF EVALUATION OF THE RELATIVE RISK OF DEVELOPING ATHEROSCLEROSIS IN PATIENTS

Biomarkers of mineralocorticoid receptor activation

NOVEL SET OF FASTING BLOOD BIOMARKERS TO DETECT PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE

Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin

Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin

Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes

METABOLIC SCREENING FOR GESTATIONAL DIABETES

THERMOELECTRIC SENSOR FOR ANALYTES IN A GAS AND RELATED METHOD

Systems and methods for electrochemical ketone detection and measurement

Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA

Compositions and methods for diagnosis and treatment of metabolic syndrome

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

Brown Adipocyte Progenitors in Human Skeletal Muscle

DIABETES PANEL

METHODS AND REAGENTS FOR THE ASSESSMENT OF GESTATIONAL DIABETES

DIABETES BIOMARKERS

Methods for quantitation of insulin levels by mass spectrometry

Methods of treating metabolic disorders

SCREENING ASSAY FOR AGENTS THAT INFLUENCE BETA CELL NUMBER AND/OR PHENOTYPE

Salivary biomarkers for monitoring of type 2 diabetes treatment

Methods of modulating the sialylation of Angptl4

Assessing renal structural alterations and outcomes

Methods of using variants of FGF19 polypeptides for the treatment of cancer

Methods of identifying subjects responsive to treatment for type 1 diabetes and compositions for treating the same

Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis

Compositions and methods for treatment of diabetic retinopathy

Composite compound comprising upconverting nanoparticle and specific receptor

Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases

BIOMARKERS ASSOCIATED WITH DIABETES AND FIBROSIS

TEST PAPER FOR DETECTION OF DIABETIC NEPHROPATHY

Diagnosis and treatment of incipient diabetes

Method for detecting risk factor for metabolic syndrome or hyperferritinemia

Type 1 Diabetes Biomarkers

Method for treating metabolic syndrome

Heptadecanoic acid supplement to human diet

Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome

SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT

DETECTION OF ALPHA, BETA-DICARBONYL COMPOUNDS WITH FLUOROGENIC PROBES

Biomarkers for cardiovascular diseases and methods using the same

Diagnosis and Risk Assessment of Pancreatic Diabetes Using MR-proADM

Anti-human CD26 monoclonal antibody or antigen-binding fragment thereof

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Compositions and methods related to structures that cross the blood brain barrier

CXCR4 and ROBO1 expression as markers for autoimmune diabetes

Computer systems for treating diseases

Treatment of insulin resistance through inhibitors of transcription factor TSC22D4

Disease-associated antigens and methods of use thereof

Method system and device for assessing insulin sensitivity

Method for reducing blood glucose

THE CHILDREN'S HOSPITAL OF PHILADELPHIA

Target for diagnosis and treatment of diabetes and cardiovascular diseases

Use of human small leucine zipper protein in adipocyte differentiation procedure

Means and Methods for Determining a Clearance Normalized Amount of a Metabolite Disease Biomarker in a Sample

ApoIII and the Treatment and Diagnosis of Diabetes

2-AAA as a Biomarker and Therapeutic Agent for Diabetes

PLASMONIC SUBSTRATE FOR MULTIPLEX ASSESSMENT OF TYPE 1 DIABETES

Method and system for model-based tracking of changes in average glycemia in diabetes

Glucagon/GLP-1 receptor co-agonists

Compostions and methods for treating chemosensory dysfunction

Biomarkers related to insulin resistance progression and methods using the same

IDENTIFICATION OF PRE-DIABETES USING A COMBINATION OF MEAN GLUCOSE AND 1,5-ANHYDROGLUCITOL MARKERS

Enolase 1 (Eno1) compositions and uses thereof

Enolase 1 (Eno1) compositions and uses thereof

Method of assessing a subject for abnormal kidney function

Methods for assaying alpha-L-iduronidase enzymatic activity

Device and method for automatic data acquisition and/or detection

Polypeptide and imaging method

Methods and compositions for use of neutrophil elastase and proteinase 3 as diagnostic biomarkers

Gas sensor element

Method of screening compounds for the treatment of diabetes

Type 2 diabetes biomarkers and uses thereof

Antibodies that bind amyloid oligomers

Prediction and prophylactic treatment of type 1 diabetes

Mucopolysaccharidosis IVA/VII screening and treatment method

GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF

Detection of oligosaccharides

Salivary inflammatory biomarkers associated with glycemic control and oral health

IDENTIFICATION OF MODULATORS OF BINDING PROPERTIES OF ANTIBODIES REACTIVE WITH A MEMBER OF THE INSULIN RECEPTOR FAMILY

Arginine vasopressin pro-hormone as predictive biomarker for diabetes

Method of diagnosing galactosemia in neonatal screening

Methods of quantifying N-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG

Marker peptide for determining risk of hyperglycemia and use thereof

Salivary protein glycosylation test for diagnosis and monitoring of diabetes

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

CMPF as a biomarker for diabetes and associated methods

Method and system to provide personalized pharmaceutical compositions and dosages

Multi-sensor array compound and methods of use thereof

Method of treating vascular insulin resistance in a normoglycemic subject based on biomarkers

COVALENTLY BOUND METABOLITES AS BIOMARKERS

APOLIPOPROTEIN CIII IN PRE- AND TYPE 2 DIABETES

Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof

Biomarkers For Diagnosis Of Diabetes And Monitoring Of Anti-Diabetic Therapy

Predicting and treating diabetic complications

Method for measuring carbohydrate metabolism ability, and composition for use in said method

METHODS FOR IDENTIFYING DIABETES DRUGS

Biomarkers for type 2 diabetes

Soluble MANF in pancreatic β-cell disorders

Anthracenyl-tetralactam macrocycles and their use in detecting a target saccharide

Novel ChREBP Isoforms and Methods Using the Same

DEVELOPMENT, CHARACTERIZATION, AND USE OF AN ANTI-HYPUSINATED eIF5A ANTIBODY TO DIAGNOSE DIABETES

METHOD FOR DETERMINING THE CONCENTRATION OF THE ADIPOCYTIC FORM OF THE FATTY ACID BINDING PROTEIN (A-FABP, FABP4, P2)

METHOD OF PROGNOSIS

Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes

Glycopeptide and uses thereof

Biomarkers For Diagnosis Of Diabetes And Monitoring Of Anti-Diabetic Therapy

Method of assessing pancreatic beta-cell function

Thermoelectric sensor for analytes in a gas and related method

Reagents and methods for detecting a polymorphic protein

Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject

Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome

Diabetes treatment support apparatus, diabetes treatment support method, diabetes treatment support program

Pharmaceutical composition for preventing or treating diabetes containing TENC1 expression or activity suppressor

Maternal biomarkers for gestational diabetes

Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same

Method of determination of risk of 2 hour blood glucose equal to or greater than 140 mg/dL

Targeted Delivery Of Autoantigens To B Cell Populations

Biomarkers for insulin resistance and methods using the same

Methods of preventing and treating diabetes by inhibiting serotonin synthesis

Blood glucose measurement unit, blood glucose measurement system comprising same

Methods and compositions for reducing blood glucose

MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES

Novel Target for Diagnosis and Treatment of Diabetes and Cardiovascular Diseases

Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

Raman spectroscopy for detection of glycated analytes

Hepatic insulin sensitizing substance and test meal for insulin sensitization

Compositions and methods for regulating glucose metabolism

Remedy for diabetes

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

System and methods for analyzing blood glucose data and quantifying the success or failure of insulin therapy

Peptide and protein biomarkers for type 1 diabetes mellitus

System and method for determining risk of diabetes based on biochemical marker analysis

Method of assessing diabetic nephropathy using CD5 antigen-like

Fructosyl peptide oxidase

ApoIII and the treatment and diagnosis of diabetes

Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

Glycopeptide and uses thereof

Glucagon/GLP-1 receptor co-agonists

Method of detection and treatment of clinically significant post-prandial hyperglycemia in normoglycemic patients

Method of treating a patient determined to be at risk of developing occult pancreatic beta-cell dysfunction

Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity

Predicting and treating diabetic complications

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-β

Diabetes-related biomarkers and methods of use thereof

DIABETES PANEL

Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease

Biosensor

Maternal biomarkers for gestational diabetes

Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases

Methods for diagnosing and treating loss or distortion of taste

CXCR4 and ROBO1 expression as markers for autoimmune diabetes

ZSCAN4 as a marker for pancreatic stem cells and progenitor cells and use thereof

Adiponectin receptor C-terminal fragments (CTF)-immunoglobulin

Method and system to provide personalized pharmaceutical compositions and dosages

Breath test device and method

Surrogates of post-translationally modified proteins and uses thereof

Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof

Methods for improving diabetes management

Method for screening substance relating to endoplasmic reticulum stress participating in onset of diabetes

Animal model for diabetic complications

Blood sugar management system

Screening method for antidiabetic agent using newly identified insulin secretion regulation factor

Bioassay method for detecting physiologically active substance

Maternal biomarkers for gestational diabetes

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Chimeric FGF21 proteins with enhanced binding affinity for β-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders

Glycated CD59 peptides, their preparation, and uses thereof

Computer systems for treating diseases

Detection method

Detection of soluble adiponectin receptor peptides and use in diagnosis and therapeutics

Assays for detection of glycosaminoglycans

Method of treating diabetes-related impaired wound healing

Method of diagnosing and treating oxidative stress-impaired wound healing

System for glycated protein detection

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

Computer systems for treating diseases

Activity based probes (ABPs) interacting with glycosidases

Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues

Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes

Method and kit for the classification and prognosis of wounds

Selective chemosensors based on the ferroelectric materials, mixed oxides, or temperature modulation of oxide polymorph stability

Method for screening diabetes treating agent

Methods for identifying a GLP-1 secretagogue

Biomarker and Method for Determining an Oxidative Stress Level

Composition comprising an angiopoietin-4 fragment

Device for detection of diabetes

Peptide and protein biomarkers for type 1 diabetes mellitus

METHODS OF SUPPRESSING CANCER, INCREASING WEIGHT LOSS AND/OR INCREASING INSULIN SENSITIVITY

Antibody that specifically binds to an epitope in the tureet region of a human Kir channel

PERIPHERIN-SPECIFIC AUTOANTIBODIES AS A MARKER FOR NEUROLOGICAL AND ENDOCRINOLOGICAL DISEASE

Screening method for an insulin resistance improving agent or a therapeutic agent for diabetes

ASSAYS AND METHODS PERTAINING TO PRE-AMYLOID INTERMEDIATES

Method For Assaying Diseases Characterized By Dyslipidemia

MICRORNA REGULATING THE INSULIN SIGNALING PATHWAY, AND METHOD FOR SCREENING MATERIAL FOR CONTROLLING THE ACTION OF A TARGET THEREOF

METHOD FOR THE DETECTION OF PREDIABETES

Glucagon/GLP-1 receptor co-agonists

Glucagon/GLP-1 receptor co-agonists

PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS

Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes

USE OF ISLET GLUCOSE-6-PHOSPHATASE RELATED PROTEIN AS A DIAGNOSTIC TOOL AND THERAPEUTIC TARGET FOR AUTOIMMUNE DIABETES